The research, published in BMC Medical Imaging by a team at Ardabil University of Medical Sciences in Iran, directly compared coronary computed tomography angiography, or CCTA, with invasive coronary angiography in 155 patients suspected of having coronary artery disease. Every patient in the study underwent both tests, allowing the investigators to measure how well the non-invasive scan performed against the gold standard. The results were striking in one direction and sobering in another: CCTA detected diseased arteries with a sensitivity of 96 percent, meaning it flagged nearly every patient who truly had significant coronary stenosis, but its specificity was just 33.3 percent, indicating that many positive findings did not hold up under invasive confirmation.

Those two numbers tell a story that cardiologists know well. Sensitivity measures how reliably a test finds disease when disease is present; specificity measures how reliably it clears patients who are actually healthy. A test with very high sensitivity and modest specificity is an excellent rule-out tool—it rarely misses a dangerous blockage—but it risks overcalling disease, which can funnel worried patients toward more invasive testing. In this cohort, CCTA achieved a positive predictive value of 85.7 percent, meaning that when the scan called a vessel diseased, it was right about six times out of seven. Its negative predictive value was 66.7 percent, and its overall accuracy came to 83.9 percent.

The study’s design was straightforward but demanding. The 155 participants, whose average age was 57.3 years and roughly two-thirds of whom were men, each underwent both imaging procedures. The researchers graded coronary stenosis—the narrowing of the arteries by plaque—into three categories: mild narrowing of 1 to 49 percent of the vessel’s diameter, moderate narrowing of 50 to 69 percent, and severe narrowing of 70 percent or more. Invasive coronary angiography served as the reference standard against which every CCTA reading was judged. This head-to-head design matters because diagnostic performance is never absolute; it depends on the population being tested, the prevalence of disease, and the threshold used to call a vessel abnormal.

One of the study’s most clinically useful findings emerged when the researchers broke the results down by individual coronary artery. The left anterior descending artery, the vessel most famously implicated in serious heart attacks, showed the highest vessel-based sensitivity at 87 percent. The left circumflex artery, which wraps around the side of the heart, proved the hardest to assess, with sensitivity dropping to 60 percent. That anatomical variation is not surprising to imaging specialists: the circumflex is smaller, more variable in its course, and often partially obscured in tomographic images, while the left anterior descending is larger and runs along the front of the heart where CT resolution is strongest.

The severity of the blockage also shaped how well the scan performed. CCTA correctly identified every case of moderate stenosis in the cohort and detected 69 percent of severe stenoses. That pattern may seem counterintuitive—surely the worst blockages should be the easiest to spot—but it reflects the physics and physiology of CT imaging. Severe, calcified plaques can cause blooming artifacts on CT, where dense calcium appears larger than it is and can obscure the true channel of blood flow. Moderate lesions, by contrast, often present a clearer target. The finding underscores that a clean CCTA report does not automatically exclude high-grade disease in every vessel, particularly in patients whose symptoms remain concerning.

Coronary artery disease remains the leading cause of death and disability worldwide, which is why the stakes of diagnostic imaging are so high. Narrowed coronary arteries starve the heart muscle of oxygen, producing angina and, when a plaque ruptures and a clot forms, myocardial infarction. The traditional pathway to diagnosis—injecting contrast through a catheter threaded from the wrist or groin into the coronary arteries—carries small but real risks of bleeding, vessel damage, arrhythmia, and radiation exposure, along with the cost and anxiety of an invasive procedure. A reliable non-invasive alternative that can safely rule out significant disease would spare countless patients a trip to the catheterization laboratory.

CCTA offers exactly that promise. The technique uses rapid, ECG-gated CT scanning synchronized to the heartbeat, with intravenous contrast opacifying the coronary lumen. Modern scanners reconstruct the moving coronary tree in three dimensions, allowing radiologists to inspect plaque burden, vessel narrowing, and even plaque composition from outside the body. Its high negative predictive value in broader populations—often above 95 percent in large multicenter trials—has made it a cornerstone of chest pain triage in emergency departments, where its main job is to send low-risk patients home quickly. The Ardabil study’s 96 percent sensitivity is consistent with that rule-out role, even though its specificity lagged in this particular high-risk group.

Why was specificity so low here? The answer likely lies in the study population and the reference standard itself. In a cohort of patients already suspected of coronary disease and referred for both tests, disease prevalence is high, which statistically depresses specificity and positive predictive value. Moreover, invasive angiography and CCTA do not measure exactly the same thing: invasive angiography shows the contrast-filled lumen of the vessel, while CCTA visualizes the vessel wall and the plaque within it. A vessel remodeled outward by plaque may look abnormal on CT but show a preserved lumen on catheterization, and vice versa. Calcification, motion artifact, and heart rate control during scanning can all degrade CT images and inflate false positives. The authors themselves note that these findings support CCTA as a useful non-invasive diagnostic tool while invasive angiography remains the reference standard for confirming stenosis.

The practical takeaway for patients and clinicians is a layered strategy rather than a replacement. CCTA, with its near-perfect sensitivity, functions best as the gatekeeper: a normal scan can reassure patients and avoid unnecessary invasive procedures, while an abnormal scan directs them toward confirmatory testing, functional assessment, or treatment. Invasive coronary angiography retains its decisive role not only in confirming anatomy but in enabling treatment—stents can be placed and pressure measurements taken during the same procedure. As scanner technology improves, with photon-counting detectors, better motion correction, and computational fluid dynamics that compute fractional flow reserve from CT images alone, the gap between the two techniques may continue to narrow. For now, this study of 155 patients offers a clear-eyed measurement of where the technology stands: superb at finding disease, imperfect at excluding it, and best used as the first, non-invasive step in a careful diagnostic sequence.

Subject of Research: Comparative diagnostic accuracy of coronary CT angiography versus invasive coronary angiography for suspected coronary artery disease

Article Title: Comparative diagnostic performance of coronary CT angiography and invasive coronary angiography in patients with suspected coronary artery disease

Article References: Farzollahzadeh, A., Shahsavari, M.-J., Mashoufi, M., Bagali, F. M., & Refahi, S. (2026). Comparative diagnostic performance of coronary CT angiography and invasive coronary angiography in patients with suspected coronary artery disease. BMC Medical Imaging, 26(1), Article 479. https://doi.org/10.1186/s12880-026-02785-3

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02785-3

Keywords: coronary artery disease, coronary CT angiography, invasive coronary angiography, diagnostic accuracy, coronary stenosis, sensitivity, specificity, medical imaging, cardiology, BMC Medical Imaging, Comparative, diagnostic